Versant Vantage I GP-GP, LLC, 10% Owner at Aprea Therapeutics, Inc. (APRE), bought 846,328 shares at $15.00 ($5.0M) on 2019-10-07, disclosed to the SEC on 2019-10-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 512,995 | $0 | 0.0% |
| 2 | $15.00 | 333,333 | $5.0M | 100.0% |
| Total | $5.91 avg | 846,328 | $5.0M | 100% |